Enhancement of the endopeptidase activity of botulinum neurotoxin by its associated proteins and dithiothreitol

被引:48
作者
Cai, SO
Sarkar, HK
Singh, BR
机构
[1] Univ Massachusetts, Dept Chem & Biochem, N Dartmouth, MA 02747 USA
[2] Univ Massachusetts, Ctr Marine Sci & Technol, N Dartmouth, MA 02747 USA
[3] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA
关键词
D O I
10.1021/bi990086c
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Botulinum neurotoxins type A (BoNT/A), the most toxic substance known to man, is produced by Clostridium botulinum type A as a complex with a group of neurotoxin-associated proteins (NAPs), possibly through a polycistronic expression of a clustered group of genes. The botulinum neurotoxin complex is the only known example of a protein complex where a group of proteins (NAPs) protect another protein (BoNT) against acidity and proteases of the GI tract. We now report that NAPs also potentiate the Zn2+ endopeptidase activity of BoNT/A in both in vitro and in vivo assays against its known intracellular target protein, 25 kDa synaptosomal associated protein (SNAP-25). While BoNT/A exhibited no protease activity prior to reduction with dithiothreitol (DTT), the BoNT/A complex exhibited a high protease activity even in its nonreduced form. Our results suggest that the bacterial production of NAPs along with BoNT is designed for the NAPs to play an accessory role in the neurotoxin function, in contrast to their previously known limited role in protecting the neurotoxin in the GI tract and in the external environment. Structural features of BoNT/A change considerably upon disulfide reduction, as revealed by near-UV circular dichroism spectroscopy. BoNT/A in the reduced form adopts a more flexible structure than in the unreduced form, as also indicated by large differences in Delta H values (155 vs 248 kJ mol(-1)) of temperature-induced unfolding of BoNT/A.
引用
收藏
页码:6903 / 6910
页数:8
相关论文
共 42 条
  • [1] DISULFIDE BONDS AND THE STABILITY OF GLOBULAR-PROTEINS
    BETZ, SF
    [J]. PROTEIN SCIENCE, 1993, 2 (10) : 1551 - 1558
  • [2] BOTULINUM NEUROTOXIN-A SELECTIVELY CLEAVES THE SYNAPTIC PROTEIN SNAP-25
    BLASI, J
    CHAPMAN, ER
    LINK, E
    BINZ, T
    YAMASAKI, S
    DECAMILLI, P
    SUDHOF, TC
    NIEMANN, H
    JAHN, R
    [J]. NATURE, 1993, 365 (6442) : 160 - 163
  • [3] Botulinum toxin therapy, immunologic resistance, and problems with available materials
    Borodic, G
    Johnson, E
    Goodnough, M
    Schantz, E
    [J]. NEUROLOGY, 1996, 46 (01) : 26 - 29
  • [4] CELL BIOLOGY - PROGRESS BY POISONING
    CUTLER, D
    [J]. NATURE, 1992, 359 (6398) : 773 - 773
  • [5] DEPAIVA A, 1993, J BIOL CHEM, V268, P20838
  • [6] DOIG AJ, 1991, J MOL BIOL, V217, P389, DOI 10.1016/0022-2836(91)90551-G
  • [7] CLONING AND SEQUENCING OF A HEMAGGLUTININ COMPONENT OF THE BOTULINUM NEUROTOXIN COMPLEX ENCODED BY CLOSTRIDIUM-BOTULINUM TYPE-A AND TYPE-B
    EAST, AK
    STACEY, JM
    COLLINS, MD
    [J]. SYSTEMATIC AND APPLIED MICROBIOLOGY, 1994, 17 (03) : 306 - 312
  • [8] DIFFERENCES IN THE PROTEASE ACTIVITIES OF TETANUS AND BOTULINUM-B TOXINS REVEALED BY THE CLEAVAGE OF VESICLE-ASSOCIATED MEMBRANE-PROTEIN AND VARIOUS SIZED FRAGMENTS
    FORAN, P
    SHONE, CC
    DOLLY, JO
    [J]. BIOCHEMISTRY, 1994, 33 (51) : 15365 - 15374
  • [9] Role of zinc in the structure and toxic activity of botulinum neurotoxin
    Fu, FN
    Lomneth, RB
    Cai, SW
    Singh, BR
    [J]. BIOCHEMISTRY, 1998, 37 (15) : 5267 - 5278
  • [10] A protease-resistant novel hemagglutinin purified from type A Clostridium botulinum
    Fu, FN
    Sharma, SK
    Singh, BR
    [J]. JOURNAL OF PROTEIN CHEMISTRY, 1998, 17 (01): : 53 - 60